SOX2 and posterior cortical atrophy: To evaluate whether SOX2 expression contributes to PCa progression, de Wet et al24 found that SOX2 expression did not independently promote an increase in tumor grade, nor did it significantly correlate with biochemical recurrence time, surgical margin status, pathological dissemination, local recurrence, or salvage therapy.24